文献速递呼吸衰竭与机械通气重症综合管理与镇静镇痛

急性呼吸衰竭患者肺保护性通气的实施

Implementation of Lung-Protective Ventilation in Patients With Acute Respiratory Failure.
PubMed 文献 · Crit Care Med · 2023-03-29
一句话结论在12家医院实施计算机化低潮气量通气方案后,潮气量≤6.5 mL/kg者从69.8%升至72.5%,但未改善无呼吸机天数、住院时间或死亡率。

本研究为实用的非随机阶梯楔形II型混合实施/效果试验,在12家医院的综合医疗系统内进行,纳入8692例在急诊科或ICU启动机械通气的成人患者(其中3282例,38%合并ARDS)。干预为在ICU实施计算机化低潮气量通气方案。实施后,初始设定潮气量中位数从6.1 mL/kg降至6.0 mL/kg(p=0.009),接受潮气量≤6.5 mL/kg者从69.8%升至72.5%(p=0.036),潮气量>8 mL/kg者从9.0%降至6.7%(p=0.005);ARDS患者第1天呼气末正压从6.7升至8.0 cm H2O(p<0.001)。但无呼吸机天数(校正OR 1.06,95%CI 0.91-1.24,p=0.44)、住院时间及死亡率均无差异。

要点

  • 实施计算机化低潮气量通气方案后,初始潮气量中位数从6.1 mL/kg(IQR 6.0-6.8)降至6.0 mL/kg(IQR 6.0-6.6)(p=0.009)。
  • 接受低潮气量通气(潮气量≤6.5 mL/kg)的患者比例从69.8%(n=1721)升至72.5%(n=1846)(p=0.036)。
  • 初始潮气量>8 mL/kg的患者比例从9.0%(n=222)降至6.7%(n=174)(p=0.005)。
  • ARDS患者第1天呼气末正压从6.7升至8.0 cm H2O(p<0.001)。
  • 无呼吸机天数(校正OR 1.06,95%CI 0.91-1.24,p=0.44)、住院时间及死亡率均无差异。

适用人群与场景

  • 年龄≥18岁、在急诊科或ICU启动机械通气的患者。
  • 排除入住ICU当天死亡或转为舒适照护的患者。
  • 定义ARDS亚组进行分析,共3282例(38%)合并ARDS。

诊断标准与关键阈值

  • 低潮气量通气定义为潮气量≤6.5 mL/kg预测体重。
  • 潮气量>8 mL/kg预测体重被视为未达标。

处置流程与药物剂量

  • 在ICU实施计算机化低潮气量通气方案。
  • 初始潮气量设定目标:中位数6.0 mL/kg预测体重(实施后)。
  • ARDS患者第1天呼气末正压中位数为8.0 cm H2O(实施后)。

研究设计与关键结果

  • 研究类型:实用的非随机阶梯楔形II型混合实施/效果试验,在综合医疗系统的12家医院进行,为期2年。
  • 样本量:纳入8692例机械通气患者,其中3282例(38%)合并ARDS。
  • 主要临床终点:无呼吸机天数至第28天,实施前后无差异(校正OR 1.06,95%CI 0.91-1.24,p=0.44)。
  • 主要过程终点:初始设定潮气量中位数从6.1 mL/kg(IQR 6.0-6.8)降至6.0 mL/kg(IQR 6.0-6.6)(p=0.009)。
  • 低潮气量通气(潮气量≤6.5 mL/kg)比例从69.8%(n=1721)升至72.5%(n=1846)(p=0.036)。
  • 潮气量>8 mL/kg比例从9.0%(n=222)降至6.7%(n=174)(p=0.005)。
  • ARDS患者第1天呼气末正压从6.7升至8.0 cm H2O(p<0.001)。
  • 住院时间及死亡率在主要队列和ARDS亚组中均无差异。

证据类型、等级与局限

  • 证据类型:实用的非随机阶梯楔形II型混合实施/效果试验。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 计算机化方案可提高低潮气量通气依从性并减少潮气量>8 mL/kg的患者数,但未改善无呼吸机天数、住院时间或死亡率。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

OBJECTIVES: We implemented a computerized protocol for low tidal volume ventilation (LTVV) to improve management and outcomes of mechanically ventilated patients with, and without, the acute respiratory distress syndrome (ARDS).

DESIGN: Pragmatic, nonrandomized stepped wedge type II hybrid implementation/effectiveness trial.

SETTING: Twelve hospitals in an integrated healthcare system over a 2-year period.

PATIENTS: Patients greater than or equal to 18 years old who had initiation of mechanical ventilation in the emergency department or ICU. We excluded patients who died or transitioned to comfort care on the day of admission to the ICU. We defined a subgroup of patients with ARDS for analysis.

INTERVENTIONS: Implementation of ventilator protocols for LTVV in the ICU.

MEASUREMENTS AND MAIN RESULTS: Our primary clinical outcome was ventilator-free days (VFDs) to day 28. Our primary process outcome was median initial set tidal volume. We included 8,692 mechanically ventilated patients, 3,282 (38%) of whom had ARDS. After implementation, set tidal volume reported as mL/kg predicted body weight decreased from median 6.1 mL/kg (interquartile range [IQR], 6.0-6.8 mL/kg) to 6.0 mL/kg (IQR, 6.0-6.6 mL/kg) ( p = 0.009). The percent of patients receiving LTVV (tidal volume ≤ 6.5 mL/kg) increased from 69.8% ( n = 1,721) to 72.5% ( n = 1,846) ( p = 0.036) after implementation. The percent of patients receiving greater than 8 mL/kg initial set tidal volume was reduced from 9.0% ( n = 222) to 6.7% ( n = 174) ( p = 0.005) after implementation. Among patients with ARDS, day 1 positive end-expiratory pressure increased from 6.7 to 8.0 cm H 2 O ( p < 0.001). We observed no difference in VFD (adjusted odds ratio, 1.06; 95% CI, 0.91-1.24; p = 0.44), or in secondary outcomes of length of stay or mortality, either within the main cohort or the subgroup of patients with ARDS.

CONCLUSIONS: We observed improved adherence to optimal ventilator management with implementation of a computerized protocol and reduction in the number of patients receiving tidal volumes greater than 8 mL/kg. We did not observe improvement in clinical outcomes.

来源:Crit Care Med,查看原文。版权归原作者所有。

参考来源

  1. Grissom CK, Lanspa MJ, Groat D, et al. Implementation of Lung-Protective Ventilation in Patients With Acute Respiratory Failure. Crit Care Med. 2023. PMID: 36988337. doi:10.1097/CCM.0000000000005840

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。